S3 Connected Health Archives - Medical Design Sourcing

S3 Connected Health joins DiMe’s International Regulatory Pathways project

NEWS RELEASE: S3 Connected Health joins DiMe’s team of digital health experts in their new project ‘International Regulatory Pathways’

DUBLIN, September 19, 2023 – Building on the success of the Digital Health US Regulatory Pathways, DiMe has assembled a global team of digital health experts, including S3 Connected Health, to support digital health product developers in pursuing and optimizing their regulatory, evidence generation, and business strategies across multiple global markets and regulatory regions.

Their new project ‘International Regulatory Pathways’ will combine the expertise and experience of the project team, with current global digital health product regulations, regulatory science, and industry pathways, to support life science companies looking to achieve accelerated access through multi-market evidence plans for digital health initiatives.

S3 Connected Health is strategically placed to bring its 20+ years of experience in bo…

Ypsomed, S3 Connected Health partner to expand digital offerings

[Image courtesy of Ypsomed and S3 Connected Health]

Ypsomed announced plans to expand its offerings of digital health solutions for chronic disease therapy together with S3 Connected Health.

Dublin, Ireland-based S3 Connected Health specializes as a digital health partner for life science companies. This partnership allows Ypsomed’s biopharma customers to quickly launch therapy-specific digital patient solutions. It enables therapy management support for acute and chronic diseases while enhancing outcomes.

Ypsomed said in a news release that the companies aim to create an extendable platform to create specific solutions. These offerings provide patients with support and guidance throughout therapy. Ypsomed’s connected injection devices, including the SmartPilot for YpsoMate, come pre-integrated into the platform.

The platform itself offers versatility and customization ca…

Ypsomed, S3 Connected Health partner to expand digital offerings

[Image courtesy of Ypsomed and S3 Connected Health]Ypsomed announced plans to expand its offerings of digital health solutions for chronic disease therapy together with S3 Connected Health.

Dublin, Ireland-based S3 Connected Health specializes as a digital health partner for life science companies. This partnership allows Ypsomed’s biopharma customers to quickly launch therapy-specific digital patient solutions. It enables therapy management support for acute and chronic diseases while enhancing outcomes.

Ypsomed said in a news release that the companies aim to create an extendable platform to create specific solutions. These offerings provide patients with support and guidance throughout therapy. Ypsomed’s connected injection devices, including the SmartPilot for YpsoMate, come pre-integrated into the platform.

The platform itself offers versatility and customization capabilities for any disease area and use case, the companies say.

The future of medtech is about connectivity and data

Here’s why medtech companies must embrace innovation, connectivity and disruption.

DeviceTalks

Healthcare must shift away from responding to acute episodes and focus on chronic and preventive care to provide better care, value, and population health. Data will inform the transition. Key questions include, “What does this mean for medtech? What role does medtech play in the future?”

The topic of innovation in healthcare — including devices, data, and disruption — was the focus of a recent episode of DeviceTalks Tuesdays, sponsored by S3 Connected Health.

Panelists included medical device experts Bill Betten, director of solutions – medtech for S3 Connected Health, and Michael Hill, PhD, retired VP of corporate science, technology and innovation at Medtronic and currently a partner at Science Innovation.

Here are five takeaways on the growing importance of data and disruption in medtech.

Get the full story on our s…

The future of medtech is about connectivity and data

Here’s why medtech companies must embrace innovation, connectivity and disruption.

DeviceTalks

Healthcare must shift away from responding to acute episodes and focus on chronic and preventive care to provide better care, value, and population health. Data will inform the transition. Key questions include, “What does this mean for medtech? What role does medtech play in the future?”

The topic of innovation in healthcare — including devices, data, and disruption — was the focus of a recent episode of DeviceTalks Tuesdays, sponsored by S3 Connected Health.

Panelists included medical device experts Bill Betten, director of solutions – medtech for S3 Connected Health, and Michael Hill, PhD, retired VP of corporate science, technology and innovation at Medtronic and currently a partner at Science Innovation.

Here are five takeaways on the growing importance of data and disruption in medtech:

1. Medical devices are becoming connected

Initially, “T…

DTW podcast: Connect your devices before it’s too late

Twenty years ago when he was working at the Mayo Clinic, cardiologist Dr. David Hayes shot down the idea that medical devices would serve patients better if equipped with technology that collected and transmitted data.

Hayes had many reasons. He said patients liked coming to the doctors’ offices. “I thought they’d miss that connection,” he said. He worried that physicians would be overwhelmed with too much data. He had other objections, too, and he’s not afraid to admit it.

“You could just check them off one-by-one,” he said in this week’s DeviceTalks Weekly podcast. “I was wrong on every one.”

Now chief medical officer for Biotronik, Hayes came around years ago and is responsible for ensuring the medical device company keeps moving forward in incorporating technology that can connect patients with physicians and hospitals. Biotronik is among the growing number of medical device companies that are examining new potential for medtech connectivity.

…

DTW podcast: Connect your devices before it’s too late

Twenty years ago when he was working at the Mayo Clinic, cardiologist Dr. David Hayes shot down the idea that medical devices would serve patients better if equipped with technology that collected and transmitted data.

Hayes had many reasons. He said patients liked coming to the doctors’ offices. “I thought they’d miss that connection,” he said. He worried that physicians would be overwhelmed with too much data. He had other objections, too, and he’s not afraid to admit it.

“You could just check them off one-by-one,” he said in this week’s DeviceTalks Weekly podcast. “I was wrong on every one.”

Now chief medical officer for Biotronik, Hayes came around years ago and is responsible for ensuring the medical device company keeps moving forward in incorporating technology that can connect patients with physicians and hospitals. Biotronik is among the growing number of medical device companies that are examining new potential for medtech connectivity.…